Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
SWX:NOVN
Novartis
|
93.49 | 8,01% | 21,37% | 190.757,59 | 3,55% | 4,67% |
|
NYSE:PFE
Pfizer
|
28.38 | 9,41% | 39,92% | 160.817,91 | 5,91% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
91.69 | 16,05% | 34,5% | 114.488,32 | 4,06% | 8,19% |
|
TSE:4568
Daiichi Sankyo Company
|
5415.00 | 0% | 0% | 10.380.257,66 | 1,11% | 0% |
|
NasdaqGS:MRNA
Moderna
|
128.32 | -.111,1% | -.107,66% | 49.177,32 | 0% | 0% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4205.00 | 0% | 0% | 6.597.366,84 | 4,78% | 0% |
|
NasdaqGS:BIIB
Biogen
|
226.88 | -13,85% | 1,44% | 33.033,02 | 0% | -10,89% |
|
XTRA:BAYN
Bayer
|
29.22 | 63,87% | 79,86% | 28.706,43 | 0,37% | 1,47% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
147.89 | 0% | 0% | 18.706,87 | 0% | 0% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
79.65 | 142,2% | 221,62% | 15.385,96 | 0% | 32,46% |
|
NasdaqGS:SRPT
Sarepta Therapeutics
|
132.66 | 0% | 0% | 12.505,49 | 0% | 0% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
105.46 | 0% | 0% | 6.783,92 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
38.27 | -.156,68% | -.149,23% | 5.756,54 | 0% | 0% |
|
NasdaqGS:DYN
Dyne Therapeutics
|
28.16 | 0% | 0% | 2.267,58 | 0% | 0% |
|
TSE:4516
Nippon Shinyaku
|
3880.00 | 0% | 0% | 261.328,78 | 3,19% | 0% |
|
NasdaqGM:WVE
Wave Life Sciences
|
5.84 | 0% | 0% | 688,23 | 0% | 0% |
|
NasdaqGS:STOK
Stoke Therapeutics
|
12.80 | 0% | 0% | 604,59 | 0% | 0% |
|
NasdaqGS:ABUS
Arbutus Biopharma
|
2.86 | 0% | 0% | 535,96 | 0% | 0% |
|
NasdaqGM:FULC
Fulcrum Therapeutics
|
7.91 | 0% | 0% | 456,83 | 0% | 0% |
|
ASX:PYC
PYC Therapeutics
|
0.10 | 0% | 0% | 294,9 | 0% | 0% |
